Biotech HTL Biotechnology inaugurates a new production line dedicated to sterile hyaluronic acid June 6, 2025
Biotech The Galien Foundation Announces 2025 Prix Galien UK Award Winners Recognising Excellence in Life Sciences Innovation June 6, 2025
Biotech GenEditBio Announces First Patient Dosed in Investigator-Initiated Trial of GEB‑101, World’s First In Vivo CRISPR-Cas Ribonucleoprotein-Based Genome Editing Investigational Therapy for TGFBI Corneal Dystrophy June 6, 2025
Biotech Preliminary Data from Two Clinical Trials with ADC Candidates were Presented Orally at the 2025 ASCO Annual Meeting June 5, 2025
Biotech Tsingke Biotech Participates in TIDES USA 2025, Demonstrates Full-Scale Oligonucleotide Synthesis Capabilities June 5, 2025
Biotech Trevi Therapeutics Announces Pricing of $100 Million Underwritten Offering of Common Stock June 4, 2025
Biotech Commit Biologics appoints leading industry experts to newly formed Scientific Advisory Board June 4, 2025
Biotech PharmaMar presents at ASCO that the Zepzelca®(lurbinectedin) and atezolizumab (Tecentriq®) combination significantly improves survival as first-line maintenance therapy for extensive-stage small cell lung cancer June 3, 2025